These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 30055794)

  • 1. French consensus: Augmentation syndrome in restless legs syndrome.
    Leu-Semenescu S; Petiau C; Charley Monaca C; Dauvilliers Y
    Rev Neurol (Paris); 2018; 174(7-8):532-539. PubMed ID: 30055794
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diagnostic standards for dopaminergic augmentation of restless legs syndrome: report from a World Association of Sleep Medicine-International Restless Legs Syndrome Study Group consensus conference at the Max Planck Institute.
    García-Borreguero D; Allen RP; Kohnen R; Högl B; Trenkwalder C; Oertel W; Hening WA; Paulus W; Rye D; Walters A; Winkelmann J; Earley CJ;
    Sleep Med; 2007 Aug; 8(5):520-30. PubMed ID: 17544323
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Guidelines for the first-line treatment of restless legs syndrome/Willis-Ekbom disease, prevention and treatment of dopaminergic augmentation: a combined task force of the IRLSSG, EURLSSG, and the RLS-foundation.
    Garcia-Borreguero D; Silber MH; Winkelman JW; Högl B; Bainbridge J; Buchfuhrer M; Hadjigeorgiou G; Inoue Y; Manconi M; Oertel W; Ondo W; Winkelmann J; Allen RP
    Sleep Med; 2016 May; 21():1-11. PubMed ID: 27448465
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification and treatment of augmentation in patients with restless legs syndrome: practical recommendations.
    Geyer J; Bogan R
    Postgrad Med; 2017 Sep; 129(7):667-675. PubMed ID: 28818004
    [TBL] [Abstract][Full Text] [Related]  

  • 5. French consensus: Treatment of newly diagnosed restless legs syndrome.
    Limousin N; Flamand M; Schröder C; Charley Monaca C
    Rev Neurol (Paris); 2018; 174(7-8):515-521. PubMed ID: 30054010
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Management of treatment failure in restless legs syndrome (Willis-Ekbom disease).
    Garcia-Borreguero D; Cano-Pumarega I; Marulanda R
    Sleep Med Rev; 2018 Oct; 41():50-60. PubMed ID: 29602660
    [TBL] [Abstract][Full Text] [Related]  

  • 7. French consensus: Pharmacoresistant restless legs syndrome.
    Chenini S; Arnulf I; Monaca CC; Ghorayeb I
    Rev Neurol (Paris); 2018; 174(7-8):522-531. PubMed ID: 30075957
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Restless legs syndrome: diagnostic assessment and the advantages and risks of dopaminergic treatment.
    Högl B; Paulus W; Clarenbach P; Trenkwalder C
    J Neurol; 2006 Aug; 253 Suppl 4():IV22-8. PubMed ID: 16944353
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Restless Legs Syndrome: Contemporary Diagnosis and Treatment.
    Gossard TR; Trotti LM; Videnovic A; St Louis EK
    Neurotherapeutics; 2021 Jan; 18(1):140-155. PubMed ID: 33880737
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Restless Legs Syndrome: clinical features, diagnosis and a practical approach to management.
    Wijemanne S; Ondo W
    Pract Neurol; 2017 Dec; 17(6):444-452. PubMed ID: 29097554
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An update on the treatment of Restless Legs Syndrome/Willis-Ekbom Disease: prospects and challenges.
    Zucconi M; Galbiati A; Rinaldi F; Casoni F; Ferini-Strambi L
    Expert Rev Neurother; 2018 Sep; 18(9):705-713. PubMed ID: 30095315
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Restless legs syndrome in the older adult: diagnosis and management.
    Milligan SA; Chesson AL
    Drugs Aging; 2002; 19(10):741-51. PubMed ID: 12390051
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacologic and Nonpharmacologic Treatment of Restless Legs Syndrome.
    Anguelova GV; Vlak MHM; Kurvers AGY; Rijsman RM
    Sleep Med Clin; 2020 Jun; 15(2):277-288. PubMed ID: 32386701
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Restless legs syndrome: pathophysiology and modern management.
    Nagandla K; De S
    Postgrad Med J; 2013 Jul; 89(1053):402-10. PubMed ID: 23524988
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Brazilian consensus on guidelines for diagnosis and treatment for restless legs syndrome.
    Fröhlich AC; Eckeli AL; Bacelar A; Poyares D; Pachito DV; Stelzer FG; Coelho FM; Rizzo GN; Prado GF; Sander HH; Goulart LI; Lucchesi LM; Gitai LL; Prado LB; Ataíde-Junior L; Bezerra ML; Lopes MC; Trentin MM; Rodrigues RN; Hasan R; Alves RS; Schönwald SV; Moraes WA
    Arq Neuropsiquiatr; 2015 Mar; 73(3):260-80. PubMed ID: 25807136
    [TBL] [Abstract][Full Text] [Related]  

  • 16. French Consensus: How to diagnose restless legs syndrome.
    Leclair-Visonneau L; Vecchierini MF; Schröder C; Charley Monaca C
    Rev Neurol (Paris); 2018; 174(7-8):508-514. PubMed ID: 30049562
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacologic and Nonpharmacologic Treatment of Restless Legs Syndrome.
    Anguelova GV; Vlak MHM; Kurvers AGY; Rijsman RM
    Sleep Med Clin; 2018 Jun; 13(2):219-230. PubMed ID: 29759272
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Frequent difficulties in the treatment of restless legs syndrome - case report and literature review.
    Narowska D; Bożek M; Krysiak K; Antczak J; Holka-Pokorska J; Jernajczyk W; Wichniak A
    Psychiatr Pol; 2015; 49(5):921-30. PubMed ID: 26688843
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Less is more: pathophysiology of dopaminergic-therapy-related augmentation in restless legs syndrome.
    Paulus W; Trenkwalder C
    Lancet Neurol; 2006 Oct; 5(10):878-86. PubMed ID: 16987735
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [When the legs have to keep moving at night--the restless legs syndrome].
    Lanz M; Happe S
    MMW Fortschr Med; 2007 May; 149 Suppl 2():42-4. PubMed ID: 17724966
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.